Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The aims of this study were to measure the pre-vaccination prevalence of oncogenic HPV infection in women aged 20-69 years who were participating in the New Zealand National Cervical Screening Programme (NZ-NCSP) and who were: (1) referred with high grade cytology with a subsequent histologically-confirmed high grade cervical intraepithelial neoplasia (CIN2/3) or adenocarcinoma in situ (AIS); or (2) were in the wider group of women who had a cytological prediction of high grade squamous disease or glandular abnormality (ASC-H/ HSIL+/AGC/AIS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP890553.RAnQBMrIIgwy2z6ukiwSgV0BrUg5j1hJ21ZzeS4vq-3ow130_assertion description "[The aims of this study were to measure the pre-vaccination prevalence of oncogenic HPV infection in women aged 20-69 years who were participating in the New Zealand National Cervical Screening Programme (NZ-NCSP) and who were: (1) referred with high grade cytology with a subsequent histologically-confirmed high grade cervical intraepithelial neoplasia (CIN2/3) or adenocarcinoma in situ (AIS); or (2) were in the wider group of women who had a cytological prediction of high grade squamous disease or glandular abnormality (ASC-H/ HSIL+/AGC/AIS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP890553.RAnQBMrIIgwy2z6ukiwSgV0BrUg5j1hJ21ZzeS4vq-3ow130_provenance.
• assertion description "[The aims of this study were to measure the pre-vaccination prevalence of oncogenic HPV infection in women aged 20-69 years who were participating in the New Zealand National Cervical Screening Programme (NZ-NCSP) and who were: (1) referred with high grade cytology with a subsequent histologically-confirmed high grade cervical intraepithelial neoplasia (CIN2/3) or adenocarcinoma in situ (AIS); or (2) were in the wider group of women who had a cytological prediction of high grade squamous disease or glandular abnormality (ASC-H/ HSIL+/AGC/AIS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The aims of this study were to measure the pre-vaccination prevalence of oncogenic HPV infection in women aged 20-69 years who were participating in the New Zealand National Cervical Screening Programme (NZ-NCSP) and who were: (1) referred with high grade cytology with a subsequent histologically-confirmed high grade cervical intraepithelial neoplasia (CIN2/3) or adenocarcinoma in situ (AIS); or (2) were in the wider group of women who had a cytological prediction of high grade squamous disease or glandular abnormality (ASC-H/ HSIL+/AGC/AIS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP305768.RAQzdCCCkatgepmbqhR0IHwCDFuD2dS6Fv8rwoFKw9i9k130_assertion description "[The aims of this study were to measure the pre-vaccination prevalence of oncogenic HPV infection in women aged 20-69 years who were participating in the New Zealand National Cervical Screening Programme (NZ-NCSP) and who were: (1) referred with high grade cytology with a subsequent histologically-confirmed high grade cervical intraepithelial neoplasia (CIN2/3) or adenocarcinoma in situ (AIS); or (2) were in the wider group of women who had a cytological prediction of high grade squamous disease or glandular abnormality (ASC-H/ HSIL+/AGC/AIS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP305768.RAQzdCCCkatgepmbqhR0IHwCDFuD2dS6Fv8rwoFKw9i9k130_provenance.
• NP736412.RAfEfZ8iU8tftizEqFCcPQ3NYtttgTseg4j17TRCgVDlw130_assertion description "[The aims of this study were to measure the pre-vaccination prevalence of oncogenic HPV infection in women aged 20-69 years who were participating in the New Zealand National Cervical Screening Programme (NZ-NCSP) and who were: (1) referred with high grade cytology with a subsequent histologically-confirmed high grade cervical intraepithelial neoplasia (CIN2/3) or adenocarcinoma in situ (AIS); or (2) were in the wider group of women who had a cytological prediction of high grade squamous disease or glandular abnormality (ASC-H/ HSIL+/AGC/AIS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP736412.RAfEfZ8iU8tftizEqFCcPQ3NYtttgTseg4j17TRCgVDlw130_provenance.
• NP548589.RAI_vfvSaoKEHKFVz4Tmt-pHeugkjtLdppAgUAyb5NQn4130_assertion description "[The aims of this study were to measure the pre-vaccination prevalence of oncogenic HPV infection in women aged 20-69 years who were participating in the New Zealand National Cervical Screening Programme (NZ-NCSP) and who were: (1) referred with high grade cytology with a subsequent histologically-confirmed high grade cervical intraepithelial neoplasia (CIN2/3) or adenocarcinoma in situ (AIS); or (2) were in the wider group of women who had a cytological prediction of high grade squamous disease or glandular abnormality (ASC-H/ HSIL+/AGC/AIS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP548589.RAI_vfvSaoKEHKFVz4Tmt-pHeugkjtLdppAgUAyb5NQn4130_provenance.
• assertion description "[The aims of this study were to measure the pre-vaccination prevalence of oncogenic HPV infection in women aged 20-69 years who were participating in the New Zealand National Cervical Screening Programme (NZ-NCSP) and who were: (1) referred with high grade cytology with a subsequent histologically-confirmed high grade cervical intraepithelial neoplasia (CIN2/3) or adenocarcinoma in situ (AIS); or (2) were in the wider group of women who had a cytological prediction of high grade squamous disease or glandular abnormality (ASC-H/ HSIL+/AGC/AIS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The aims of this study were to measure the pre-vaccination prevalence of oncogenic HPV infection in women aged 20-69 years who were participating in the New Zealand National Cervical Screening Programme (NZ-NCSP) and who were: (1) referred with high grade cytology with a subsequent histologically-confirmed high grade cervical intraepithelial neoplasia (CIN2/3) or adenocarcinoma in situ (AIS); or (2) were in the wider group of women who had a cytological prediction of high grade squamous disease or glandular abnormality (ASC-H/ HSIL+/AGC/AIS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1057045.RAUtlc84aRWxEdqUUpubfj2S2dZGLCgTojJdawQKHAUt0130_assertion description "[The aims of this study were to measure the pre-vaccination prevalence of oncogenic HPV infection in women aged 20-69 years who were participating in the New Zealand National Cervical Screening Programme (NZ-NCSP) and who were: (1) referred with high grade cytology with a subsequent histologically-confirmed high grade cervical intraepithelial neoplasia (CIN2/3) or adenocarcinoma in situ (AIS); or (2) were in the wider group of women who had a cytological prediction of high grade squamous disease or glandular abnormality (ASC-H/ HSIL+/AGC/AIS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1057045.RAUtlc84aRWxEdqUUpubfj2S2dZGLCgTojJdawQKHAUt0130_provenance.
• NP253260.RAl7Md4WCMZAlzso56YFyLEsOPLCzuwNBgmIHHqZP1rb8130_assertion description "[The aims of this study were to measure the pre-vaccination prevalence of oncogenic HPV infection in women aged 20-69 years who were participating in the New Zealand National Cervical Screening Programme (NZ-NCSP) and who were: (1) referred with high grade cytology with a subsequent histologically-confirmed high grade cervical intraepithelial neoplasia (CIN2/3) or adenocarcinoma in situ (AIS); or (2) were in the wider group of women who had a cytological prediction of high grade squamous disease or glandular abnormality (ASC-H/ HSIL+/AGC/AIS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP253260.RAl7Md4WCMZAlzso56YFyLEsOPLCzuwNBgmIHHqZP1rb8130_provenance.
• NP893314.RAPQRAHDv0XWlSIAlfG7IsJpZwoRTJMDXUsjUtp7qYBLY130_assertion description "[The aims of this study were to measure the pre-vaccination prevalence of oncogenic HPV infection in women aged 20-69 years who were participating in the New Zealand National Cervical Screening Programme (NZ-NCSP) and who were: (1) referred with high grade cytology with a subsequent histologically-confirmed high grade cervical intraepithelial neoplasia (CIN2/3) or adenocarcinoma in situ (AIS); or (2) were in the wider group of women who had a cytological prediction of high grade squamous disease or glandular abnormality (ASC-H/ HSIL+/AGC/AIS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP893314.RAPQRAHDv0XWlSIAlfG7IsJpZwoRTJMDXUsjUtp7qYBLY130_provenance.
• NP893514.RAPoafnXvpPD2yh0eDjO_A7I3c2JPIeGsdO-P7Hr-qKFs130_assertion description "[The aims of this study were to measure the pre-vaccination prevalence of oncogenic HPV infection in women aged 20-69 years who were participating in the New Zealand National Cervical Screening Programme (NZ-NCSP) and who were: (1) referred with high grade cytology with a subsequent histologically-confirmed high grade cervical intraepithelial neoplasia (CIN2/3) or adenocarcinoma in situ (AIS); or (2) were in the wider group of women who had a cytological prediction of high grade squamous disease or glandular abnormality (ASC-H/ HSIL+/AGC/AIS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP893514.RAPoafnXvpPD2yh0eDjO_A7I3c2JPIeGsdO-P7Hr-qKFs130_provenance.
• NP1057044.RA1EWU16Bz3XdEKKnbrKaJf8-pUVs0hhhpvrcDNYz1HC4130_assertion description "[The aims of this study were to measure the pre-vaccination prevalence of oncogenic HPV infection in women aged 20-69 years who were participating in the New Zealand National Cervical Screening Programme (NZ-NCSP) and who were: (1) referred with high grade cytology with a subsequent histologically-confirmed high grade cervical intraepithelial neoplasia (CIN2/3) or adenocarcinoma in situ (AIS); or (2) were in the wider group of women who had a cytological prediction of high grade squamous disease or glandular abnormality (ASC-H/ HSIL+/AGC/AIS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1057044.RA1EWU16Bz3XdEKKnbrKaJf8-pUVs0hhhpvrcDNYz1HC4130_provenance.